Rejection of the Component Tissues of Limb Allografts in Rats Immunosuppressed with FK-506 and Cyclosporine

[1]  B. Greenbaum,et al.  Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  K. Black,et al.  Histochemical properties of muscle allografts enhanced via cyclosporine. , 1989, Transplantation.

[3]  C. Hewitt,et al.  Comparative studies of FK506 with cyclosporine. , 1988, Transplantation.

[4]  A. Aguinaldo,et al.  Pathologic alterations in the skin component of composite tissue and skin allografts treated with cyclosporine. , 1988, Transplantation proceedings.

[5]  K. Black,et al.  Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. , 1988, Transplantation proceedings.

[6]  K. Black,et al.  Two new composite tissue allograft models in rats to study neuromuscular functional return. , 1987, Transplantation proceedings.

[7]  R. Gale.  Graft‐versus‐Host Disease , 1985 .

[8]  K. Black,et al.  COMPOSITE TISSUE (LIMB) ALLOGRAFTS IN RATS: II. INDEFINITE SURVIVAL USING LOW‐DOSE CYCLOSPORINE , 1985, Transplantation.

[9]  D. C. Martin,et al.  COMPOSITE TISSUE (LIMB) ALLOGRAFTS IN RATS: I. DOSE‐DEPENDENT INCREASE IN SURVIVAL WITH CYCLOSPORINE , 1985, Transplantation.

[10]  W. Swartz,et al.  Limb Allografts in Rats Immunosuppressed with Cyclosporin A , 1984, Annals of surgery.

[11]  C. Margarit,et al.  Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection? , 1988, Transplantation proceedings.